Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Azithromycin and genital infections]

M Micoud1, L F Pépin

  • 1Clinique Médicale et des Maladies Infectieuses, CHU, Grenoble, France.

Pathologie-Biologie
|June 1, 1995
PubMed
Summary

Azithromycin offers an effective single-dose treatment for Chlamydia trachomatis lower genital tract infections, achieving 98% bacterial eradication. This macrolide antibiotic demonstrates good tolerability and compliance, crucial for successful treatment outcomes in young patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of lower respiratory tract infections by general practitioners in France].

Revue des maladies respiratoires·2001
Same author

Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders?

AIDS research and human retroviruses·2000
Same author

[Experience with an "isolation unit" for patients infected with multi-resistant bacteria. Retrospective study of 49 patients].

Presse medicale (Paris, France : 1983)·1999
Same author

[A flash of lightning that makes one anuric].

La Revue de medecine interne·1999
Same author

Association between primary cytomegalovirus infection and severe hemolytic anemia in an immunocompetent adult.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1999
Same author

[Meningoencephalitis caused by Toxocara canis].

Annales de medecine interne·1998

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Lower genital tract infections caused by Chlamydia trachomatis are common, especially in young individuals.
  • These infections can lead to severe complications, including sterility in women.
  • Effective treatment requires good patient compliance, emphasizing ease of administration and tolerability.

Purpose of the Study:

  • To evaluate the efficacy and advantages of azithromycin for treating Chlamydia trachomatis infections.
  • To assess azithromycin's activity against Chlamydia trachomatis in vitro and in vivo.
  • To compare azithromycin's clinical effectiveness with standard treatments.

Main Methods:

  • In vitro susceptibility testing of azithromycin against Chlamydia trachomatis strains.
  • Animal models to assess curative and prophylactic activity against Chlamydia trachomatis infections.
  • Clinical studies comparing single-dose azithromycin (1g) with reference treatments.

Main Results:

  • Azithromycin exhibits potent in vitro activity against Chlamydia trachomatis (MIC 0.06-0.125 µg/ml).
  • Animal studies demonstrated curative and prophylactic efficacy, preventing salpingitis.
  • Clinical trials showed 98% bacterial eradication with single-dose azithromycin, comparable to reference treatments.

Conclusions:

  • Azithromycin is a highly effective and well-tolerated single-dose treatment for Chlamydia trachomatis lower genital tract infections.
  • Its favorable compliance profile makes it advantageous for treating young patients.
  • Limitations include variable activity against Neisseria gonorrhoeae and lack of efficacy against Mycoplasma hominis.

Related Experiment Videos